Gene: SPATA13
Official Full Name: spermatogenesis associated 13provided by HGNC
Gene Summary: Enables guanyl-nucleotide exchange factor activity and identical protein binding activity. Involved in cell migration; plasma membrane bounded cell projection assembly; and regulation of cell migration. Located in several cellular components, including filopodium; lamellipodium; and ruffle membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27537 | SPATA13 Knockout cell line (HeLa) | Human | SPATA13 | 1:3~1:6 | Negative | Online Inquiry |
KO27538 | SPATA13 Knockout cell line (HCT 116) | Human | SPATA13 | 1:2~1:4 | Negative | Online Inquiry |
KO27539 | SPATA13 Knockout cell line (HEK293) | Human | SPATA13 | 1:3~1:6 | Negative | Online Inquiry |
KO27540 | SPATA13 Knockout cell line (A549) | Human | SPATA13 | 1:3~1:4 | Negative | Online Inquiry |
SPATA13 Gene Knockout Cell Lines are precisely engineered cellular models that have undergone targeted genetic modification to ablate the expression of the SPATA13 gene. SPATA13, which plays a critical role in the regulation of cellular processes such as mitotic spindle orientation, signaling pathways, and cytoskeletal dynamics, is essential for maintaining proper cellular function. The knockout of this gene allows researchers to investigate its direct effects on various cellular mechanisms, enabling deeper insights into developmental biology, cancer progression, and potential therapeutic targets.
These cell lines operate through the CRISPR-Cas9 gene editing system, a revolutionary tool that enables precise modifications at the genomic level. By elucidating the function of SPATA13 through gene knockout, users can assess alterations in cell behavior, migration, and proliferation, contributing to a better understanding of cellular architecture and disease states. This underscores the scientific importance of SPATA13 Gene Knockout Cell Lines in both academic and clinical research settings, where elucidating gene function can lead to novel treatment strategies.
Compared to alternative cell models, our SPATA13 Gene Knockout Cell Lines offer unparalleled specificity and reproducibility, significantly reducing off-target effects that often accompany traditional knockdown methodologies. In addition, they are available with a comprehensive support package that includes characterization data and customization options, making it easier for researchers to integrate these models into their studies.
Researchers and clinicians benefit from using SPATA13 Gene Knockout Cell Lines as they provide robust experimental frameworks to study gene function in a controlled environment, facilitate drug discovery processes, and contribute to the development of gene-targeted therapies. Their detailed characterization ensures reliable results that can be translated into meaningful biological insights.
Our company specializes in cutting-edge genetic engineering technologies and offers an extensive portfolio of knockout cell lines suited for various research needs. With a commitment to scientific excellence and customer support, we empower researchers with innovative tools to advance their studies and drive breakthroughs in health and disease research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.